Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113980028A details a novel organocatalytic route for chiral spiro indolones. This method offers mild conditions, high stereoselectivity, and scalable manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-purity indolo derivatives. This patent offers cost-effective scale-up solutions for global pharmaceutical intermediates manufacturing supply chains.
Patent CN112209850A details an efficient NHC-catalyzed asymmetric synthesis route for beta-amino acid intermediates, offering superior chiral control and scalable manufacturing capabilities for global supply chains.
Patent CN113087689B reveals a metal-free synthesis for 5-amino-gamma-lactones. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Discover a novel asymmetric synthesis method for axially chiral indole-naphthalene compounds using chiral phosphoric acid. High enantioselectivity and mild conditions for API manufacturing.
Patent CN106478720B details a metal-free oxazoline catalyst enabling high-purity pharmaceutical intermediates with reduced environmental impact and scalable production capabilities.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds with high enantioselectivity for pharmaceutical applications.
Patent CN108864110B reveals a novel organocatalytic route for anticancer naphthoquinopyrans, offering improved safety and scalability for pharmaceutical intermediate manufacturing.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing potential.
Patent CN108558692B reveals a mild NHC-catalyzed amidation route offering high yields and simplified purification for cost-effective pharmaceutical intermediate manufacturing.
Patent CN102260129A reveals a mild N-heterocyclic carbene catalyzed esterification. This technology offers significant cost reduction in ester manufacturing and enhanced supply chain reliability.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Delivers high optical purity and cost reduction in fine chemical manufacturing for global supply chains.
Novel binaphthyl phosphoric acid catalysis enables mild synthesis of antitumor intermediates with significant supply chain and cost advantages for global buyers.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel 5 5 tetralone skeleton chiral phosphoric acid patent CN105111228A offers enhanced acidity and enantioselectivity for pharmaceutical intermediates with cost effective synthesis